Drug-induced lung disease adverse effect with Ledipasvir Acetonate/Sofosbuvir

BACKGROUND: Interferon and ribavirin have been used as therapeutic agents for chronic hepatitis C infection or C-compensated cirrhosis in the conventional treatment. Hepatitis C virus (HCV) -specific direct-acting antiviral agents that directly inhibit the growth process of HCV have been approved si...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pharm Health Care Sci
Hlavní autoři: Omotani, Sachiko, Ishizaka, Toshihiko, Inoue, Miki, Nishida, Koji, Yasui, Yukako, Hatsuda, Yasutoshi, Mukai, Junji, Myotoku, Michiaki
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7114806/
https://ncbi.nlm.nih.gov/pubmed/32266075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-020-00162-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky